No Data
No Data
Individual Investors Are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) Biggest Owners and Were Hit After Market Cap Dropped US$26m
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Diamedica Therapeutics (DMAC)
DiaMedica Therapeutics Management to Meet Virtually With Lake Street
DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia
Express News | DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of Dm199 for the Treatment of Preeclampsia
DiaMedica Therapeutics (NASDAQ:DMAC) Is In A Good Position To Deliver On Growth Plans
No Data